Cancer Institute of New Jersey (CINJ), Urologic Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Urologic Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Prostatic Neoplasms Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgens Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

Parathyroid Hormone-Related Protein
Prostatic Neoplasms
Castration
Cell Line
Catenins
Neoplastic Stem Cells
Prostate
Heterografts
Therapeutics
Neoplasms
Prostatic Neoplasms
Research
Education
Patient Care
Research Personnel

Research Output 1984 2019

13 Citations (Scopus)

A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: Efficacy and biomarkers

Beltran, H., Oromendia, C., Danila, D. C., Montgomery, B., Hoimes, C., Szmulewitz, R. Z., Vaishampayan, U., Armstrong, A. J., Stein, M., Pinski, J., Mosquera, J. M., Sailer, V., Bareja, R., Romanel, A., Gumpeni, N., Sboner, A., Dardenne, E., Puca, L., Prandi, D., Rubin, M. A. & 6 others, Scher, H. I., Rickman, D. S., Demichelis, F., Nanus, D. M., Ballman, K. V. & Tagawa, S. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 43-51 9 p.

Research output: Contribution to journalArticle

Aurora Kinases
Castration
Tumor Biomarkers
Prostatic Neoplasms
Organoids

AUTHOR REPLY

Farber, N. J., Neylan, C. J., Singer, E. A. & Elsamra, S. E., Jun 2019, In : Urology. 128, p. 29-30 2 p.

Research output: Contribution to journalComment/debate

12 Citations (Scopus)

Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

Haas, N. B., Appleman, L. J., Stein, M., Redlinger, M., Wilks, M., Xu, X., Onorati, A., Kalavacharla, A., Kim, T., Zhen, C. J., Kadri, S., Segal, J. P., Gimotty, P. A., Davis, L. E. & Amaravadi, R. K., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2080-2087 8 p.

Research output: Contribution to journalArticle

Hydroxychloroquine
Autophagy
Renal Cell Carcinoma
Disease-Free Survival
Everolimus